David began his venture capital career in 1997. Prior to founding Correlation Ventures, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund based in San Diego. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering. David received an M.B.A. from the Harvard Graduate School of Business Administration and graduated Summa Cum Laude with a B.S. in Biology from Princeton University.
David is attending / has attended:
The 2017 New England Venture Summit
Venture Summit | West 2016
Venture Summit | West 2013
The Life Sciences and Healthcare Venture Summit 2012
The 2011 New England Venture Summit